Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i


Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes

  • Published Date:

    Mar 2005

  • Source:
    Emerg Infect Dis. 11(3):411-416.
Filetype[PDF-203.46 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 329.93 KB]
    Personal Author:
    Xu, Dongping ; Zhang, Zheng ; ...
    Published Date:
    May 2004
    Source:
    Emerg Infect Dis. 10(5):789-794.
    Description:
    To characterize genetic variation of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) transmitted in the Beijing area during the ep...
    File Type:
    Filetype[PDF - 329.93 KB]
    File Type:
    Filetype[PDF - 329.93 KB]
  2. Filetype[PDF - 189.37 KB]
    Personal Author:
    Wang, Ming ; Yan, Meiying ; ...
    Published Date:
    Dec 2005
    Source:
    Emerg Infect Dis. 11(12):1860-1865.
    Description:
    Epidemiologic investigations showed that 2 of 4 patients with severe acute respiratory syndrome (SARS) identified in the winter of 2003-2004 were a wa...
    File Type:
    Filetype[PDF - 189.37 KB]
    File Type:
    Filetype[PDF - 189.37 KB]
  3. Filetype[PDF - 196.37 KB]
    Personal Author:
    Liang, Guodong ; Chen, Qiuxia ; ...
    Corporate Authors:
    SARS Diagnosis Working Group
    Published Date:
    Oct 2004
    Source:
    Emerg Infect Dis. 10(10):1774-1781.
    Description:
    Four cases of severe acute respiratory syndrome (SARS) that occurred from December 16, 2003, to January 8, 2004, in the city of Guangzhou, Guangdong P...
    File Type:
    Filetype[PDF - 196.37 KB]
    File Type:
    Filetype[PDF - 196.37 KB]
  4. Filetype[PDF - 95.26 KB]
    Personal Author:
    Jiang, Shibo ; He, Yuxian ; ...
    Published Date:
    Jul 2005
    Source:
    Emerg Infect Dis. 11(7):1016-1020.
    Description:
    Developing effective and safe vaccines is urgently needed to prevent infection by severe acute respiratory syndrome (SARS)-associated coronavirus (SAR...
    File Type:
    Filetype[PDF - 95.26 KB]
    File Type:
    Filetype[PDF - 95.26 KB]
  5. Filetype[PDF - 225.67 KB]
    Personal Author:
    Wu, Li-Ping ; Wang, Nai-Chang ; ...
    Published Date:
    Oct 2007
    Source:
    Emerg Infect Dis. 13(10):1562-1564.
    Description:
    Among 176 patients who had had severe acute respiratory syndrome (SARS), SARS-specific antibodies were maintained for an average of 2 years, and signi...
    File Type:
    Filetype[PDF - 225.67 KB]
    File Type:
    Filetype[PDF - 225.67 KB]